71 related articles for article (PubMed ID: 23794094)
1. A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.
Giacomazzi J; Koehler-Santos P; Palmero EI; Graudenz MS; Rivero LF; Lima E; Pütten AC; Hainaut P; Camey SA; Michelli RD; Neto CS; Fitarelli-Kiehl M; Geyer G; Meurer L; Geiger A; Azevedo MB; da Silva VD; Ashton-Prolla P
Virchows Arch; 2013 Jul; 463(1):17-22. PubMed ID: 23794094
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Giacomazzi J; Graudenz MS; Osorio CA; Koehler-Santos P; Palmero EI; Zagonel-Oliveira M; Michelli RA; Scapulatempo Neto C; Fernandes GC; Achatz MI; Martel-Planche G; Soares FA; Caleffi M; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
PLoS One; 2014; 9(6):e99893. PubMed ID: 24936644
[TBL] [Abstract][Full Text] [Related]
3. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
Pinto EM; Fridman C; Figueiredo BC; Salvador H; Teixeira MR; Pinto C; Pinheiro M; Kratz CP; Lavarino C; Legal EAMF; Le A; Kelly G; Koeppe E; Stoffel EM; Breen K; Hahner S; Heinze B; Techavichit P; Krause A; Ogata T; Fujisawa Y; Walsh MF; Rana HQ; Maxwell KN; Garber JE; Rodriguez-Galindo C; Ribeiro RC; Zambetti GP
HGG Adv; 2024 Jan; 5(1):100244. PubMed ID: 37794678
[TBL] [Abstract][Full Text] [Related]
4. The Clinical and Molecular Profile of Lung Cancer Patients Harboring the
Lopes CDH; Antonacio FF; Moraes PMG; Asprino PF; Galante PAF; Jardim DL; de Macedo MP; Sandoval RL; Katz A; de Castro G; Achatz MI
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894716
[TBL] [Abstract][Full Text] [Related]
5. Mouse Homolog of the Human
Park JH; Li J; Starost MF; Liu C; Zhuang J; Chen J; Achatz MI; Kang JG; Wang PY; Savage SA; Hwang PM
Cancer Res; 2018 Sep; 78(18):5375-5383. PubMed ID: 30042151
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the Brazilian
Vieira IA; Andreis TF; Fernandes BV; Achatz MI; Macedo GS; Schramek D; Ashton-Prolla P
Front Genet; 2021; 12():606537. PubMed ID: 33603772
[TBL] [Abstract][Full Text] [Related]
7. Calibrating cancer risk, uncertainty and environments: Genetics and their contexts in southern Brazil.
Gibbon S
Biosocieties; 2018 Dec; 13(4):761-779. PubMed ID: 30976288
[TBL] [Abstract][Full Text] [Related]
8. Comparison of mutation profile between primary phyllodes tumors of the breast and their paired local recurrences.
Mitus J; Adamczyk A; Majchrzyk K; Kowalik A; Ryś J; Niemiec J
Pol J Pathol; 2020; 71(1):7-12. PubMed ID: 32429649
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study.
Chen K; Xu J; Wang W; Jiang R; Zhang H; Wang X; Cao J; Fang M
Cancer Med; 2023 May; 12(10):11363-11374. PubMed ID: 37081723
[TBL] [Abstract][Full Text] [Related]
10. Phyllodes Tumors: A Scoping Review of the Literature.
Bogach J; Shakeel S; Wright FC; Hong NJL
Ann Surg Oncol; 2022 Jan; 29(1):446-459. PubMed ID: 34296360
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.
Funato M; Tsunematsu Y; Yamazaki F; Tamura C; Kumamoto T; Takagi M; Kato S; Sugimura H; Tamura K
Cancer Sci; 2021 May; 112(7):2821-34. PubMed ID: 33932062
[TBL] [Abstract][Full Text] [Related]
12. Malignant Phyllodes Tumor of the Breast: A Practice Review.
Fede ÂBS; Pereira Souza R; Doi M; De Brot M; Aparecida Bueno de Toledo Osorio C; Rocha Melo Gondim G; Casali-da-Rocha JC; Jbili R; Bitencourt AGV; Alves de Souza J; Caparica Bitton R; Baroni Alves Makdissi F; Moraes Sanches S
Clin Pract; 2021 Apr; 11(2):205-215. PubMed ID: 33917271
[TBL] [Abstract][Full Text] [Related]
13. Germline
Evans DG; Woodward ER; Bajalica-Lagercrantz S; Oliveira C; Frebourg T
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327514
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines.
Rosenberger LH; Thomas SM; Nimbkar SN; Hieken TJ; Ludwig KK; Jacobs LK; Miller ME; Gallagher KK; Wong J; Neuman HB; Tseng J; Hassinger TE; King TA; Jakub JW
J Clin Oncol; 2021 Jan; 39(3):178-189. PubMed ID: 33301374
[TBL] [Abstract][Full Text] [Related]
15. What 20 years of research has taught us about the TP53 p.R337H mutation.
Pinto EM; Zambetti GP
Cancer; 2020 Nov; 126(21):4678-4686. PubMed ID: 32875577
[TBL] [Abstract][Full Text] [Related]
16. Germline Genetic Mutations in a Multi-center Contemporary Cohort of 550 Phyllodes Tumors: An Opportunity for Expanded Multi-gene Panel Testing.
Rosenberger LH; Thomas SM; Nimbkar SN; Hieken TJ; Ludwig KK; Jacobs LK; Miller ME; Gallagher KK; Wong J; Neuman HB; Tseng J; Hassinger TE; Jakub JW
Ann Surg Oncol; 2020 Oct; 27(10):3633-3640. PubMed ID: 32504368
[TBL] [Abstract][Full Text] [Related]
17. TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
Hahn EC; Bittar CM; Vianna FSL; Netto CBO; Biazús JV; Cericatto R; Cavalheiro JA; de Melo MP; Menke CH; Rabin E; Leistner-Segal S; Ashton-Prolla P
PLoS One; 2018; 13(12):e0209934. PubMed ID: 30596752
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H in TP53.
Fitarelli-Kiehl M; Macedo GS; Schlatter RP; Koehler-Santos P; Matte Uda S; Ashton-Prolla P; Giacomazzi J
Genet Mol Biol; 2016 Jun; 39(2):203-9. PubMed ID: 27275664
[TBL] [Abstract][Full Text] [Related]
19. Phyllodes tumours of the breast: a consensus review.
Tan BY; Acs G; Apple SK; Badve S; Bleiweiss IJ; Brogi E; Calvo JP; Dabbs DJ; Ellis IO; Eusebi V; Farshid G; Fox SB; Ichihara S; Lakhani SR; Rakha EA; Reis-Filho JS; Richardson AL; Sahin A; Schmitt FC; Schnitt SJ; Siziopikou KP; Soares FA; Tse GM; Vincent-Salomon A; Tan PH
Histopathology; 2016 Jan; 68(1):5-21. PubMed ID: 26768026
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
